Thiadiazolediamine derivative with histamine H-2 receptor inhibi

Details Thiadiazolediamine derivative with histamine H-2 receptor inhibi Thiadiazolediamine derivative with histamine H-2 receptor inhibi

1983-09-22

1985-07-16

Bond, Robert T.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

546209, A61K 31445, C07D41712

Patent

active

045297312

ABSTRACT:
N-[2-(dimethylamino)ethyl]-N'-[3-[3-[(1-piperidinyl)methyl]phenoxy]-propyl] -1,2,5-thiadiazole-3,4-diamine, 1-oxide is a long acting histamine H-2 receptor antagonist. The compound inhibits gastric acid secretion, and prevents and alleviates ulcers.

REFERENCES:
patent: 4374248 (1983-02-01), Crenshaw et al.
patent: 4380638 (1983-04-01), Crenshaw et al.
patent: 4380639 (1983-04-01), Crenshaw et al.

Affiliated with

Also associated with

Rating

Thiadiazolediamine derivative with histamine H-2 receptor inhibi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thiadiazolediamine derivative with histamine H-2 receptor inhibi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiadiazolediamine derivative with histamine H-2 receptor inhibi will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1736513